http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum
-
Rapid Micro Biosystems to Present at TD Cowen 46th Annual Health Care Conference
-
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
-
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Rapid Micro Biosystems reports record Q4 2025 revenue of $11.3 million
-
Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
-
Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance
-
Rapid Micro Biosystems to Participate in the Stifel 2025 Healthcare Conference
-
Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025
-
Trinity Capital Inc. Provides $45 Million in Growth Capital to Rapid Micro Biosystems, Modernizing Healthcare Industry Practices
-
Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results
-
Rapid Micro Biosystems secures $45 million loan from Trinity Capital
-
Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.
-
Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025
-
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Rapid Micro Biosystems (RPID) Appoints Dafni Bika to its Board
-
Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors
-
Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
-
Rapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025
-
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance
-
Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany
-
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
-
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025
-
Rapid Micro Biosystems (RPID) Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue
-
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue
-
Rapid Micro Biosystems to Present at 43ʳᵈ Annual J.P. Morgan Healthcare Conference
-
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference
-
Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results
-
Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024
-
Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
-
Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results
-
Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024
-
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
-
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024
-
Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024
-
Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
-
Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
-
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
-
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
-
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
-
Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System
-
Rapid Micro Biosystems (RPID) Reports Prelim Q4 and 2023 Revenue
-
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue
-
Rapid Micro Biosystems (RPID) Selected by Samsung Biologics to Automate Critical Microbiology Quality Control Testing
-
Samsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testing
-
Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference

